BNTX

NASDAQ 已收盘

BioNTech SE

81.38 USD
▼-1.88-2.26%
盘后 80.78 -0.74%
2026-11-19
市值
$20.14B
市盈率
—
EPS
-6.68
股息率
—
52 周区间
79.52 – 124.00
成交量
1.50M
Beta
1.33
目标价
112.22
52W 低 79.5252W 高 124.00
价格走势

公司简介

BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 cli...

关联新闻